COMPANY PROFILE / #2215
28bio
New Orleans, LAVenture Capital-Backed
OVERVIEW
Developer of a brain-on-a-chip platform designed to capture neurological processes in the brain and nervous system. The company's platform utilizes tissue engineering, neural interfacing and artificial intelligence to measure clinically relevant electrophysiology data analyzed by models, enabling healthcare professionals to treat neurological diseases.
已融资24.03
最新估值83.68
员工数19
成立年份2014
公司概况
- Companies
- 28bio
- Description
- Developer of a brain-on-a-chip platform designed to capture neurological processes in the brain and nervous system. The company's platform utilizes tissue engineering, neural interfacing and artificial intelligence to measure clinically relevant electrophysiology data analyzed by models, enabling healthcare professionals to treat neurological diseases.
- Website
- www.28bio.com
- HQ Location
- New Orleans, LA
- Year Founded
- 2014
- Keywords
- artificial intelligence, disease model, electrophysiology product, nervous system, neurological care, peripheral neuropathy
- Competitors
- Hesperos, Thrive Bioscience, Aspect Biosystems, Quad Technologies, InSphero, StemoniX, Ncardia, CN-Bio, Axiogenesis, MIMETAS, Moraga Biotechnology Corporation, Emulate, DefiniGEN, VivoSim Labs, MatTek, TissUse, iXCells Biotechnologies, Osiris Therapeutics, OcellO, AllCells, Treefrog Therapeutics, Lisata Therapeutics, Nagi Bioscience, Capricor Therapeutics, Nanofiber Solutions, ScienCell Research Laboratories, Centrexion Therapeutics, Qihan Biotech, Axol Bioscience, 3D Biotek, Pluriomics, StemCell Technologies, Prothena, Numa (Other Devices and Supplies), Cell Applications, TARA Biosystems, Akron Biotech, Cerapedics, Arzneimittelwerke Warngau, AVM Biotechnology
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 24.03
- First Financing Date
- 01-Jan-2014
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 27-Jan-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 6.53
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 83.68
- Last Known Valuation Date
- 22-Nov-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 121.70
- Valuation Estimate Growth Rate
- 45.43%
- Active Investors
- Acadian Capital Group, Benson Capital Partners, Great Stuff Ventures, Jefferson Capital Partners, Johns Hopkins Technology Ventures, Laconia Ventures, National Center For Advancing Translational Sciences, National Institute of Environmental Health Sciences, New Orleans BioInnovation Center, New Orleans Entrepreneur Week, New Orleans Startup Fund, The Idea Village, Tulane University, U.S. Department of Health and Human Services, United States Department of War, US National Science Foundation, Yellow Ventures (South Carolina)
- # Active Investors
- 17
- Acquirers
- —
团队与联系人
- Employees
- 19
- Employee Growth %
- -13.64%
- Employee History
- 2025: 19, 2024: 22, 2023: 34, 2022: 20, 2021: 24, 2020: 27, 2019: 20 E, 2018: 12
- Primary Contact
- —
- Primary Contact Title
- —
- Primary Contact Email
- —
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- —
- Size Multiple
- —
- Size Multiple % Change
- —
- Size Multiple Change
- —
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 22%
- Success Probability Over Time – 3 Year
- 32%
- Success Probability Over Time – 5 Year
- 40%
记录来源：public.companies · 原始序号 #2215 · 所有字段均按数据库原值展示。